Stay updated on ONO-4538 in NSCLC Clinical Trial
Sign up to get notified when there's something new on the ONO-4538 in NSCLC Clinical Trial page.

Latest updates to the ONO-4538 in NSCLC Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page has been updated to include new information about the drug Bevacizumab and its trial ONO-4538-52, while significant details about the study's purpose, inclusion and exclusion criteria, and the previous revision have been removed.SummaryDifference8%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check37 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
- Check88 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
Stay in the know with updates to ONO-4538 in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ONO-4538 in NSCLC Clinical Trial page.